Arbutus Biopharma
ABUS
#6327
Rank
NZ$1.05 B
Marketcap
$5.52
Share price
-1.50%
Change (1 day)
20.40%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2024 (TTM): -NZ$0.12 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are NZ$6.17 Million. , an increase over its 2023 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.12 Billion-4.02%
2023 -NZ$0.13 Billion12.05%
2022 -NZ$0.11 Billion-14.74%
2021 -NZ$0.13 Billion19.61%
2020 -NZ$0.11 Billion-61.69%
2019 -NZ$0.28 Billion171.23%
2018 -NZ$0.11 Billion-43.58%
2017 -NZ$0.19 Billion-77.77%
2016 -NZ$0.83 Billion532.77%
2015 -NZ$0.13 Billion99.05%
2014 -NZ$65.13 Million175.82%
2013 -NZ$23.62 Million-143.7%
2012 NZ$54.03 M-399.11%
2011 -NZ$18.07 Million-39.03%
2010 -NZ$29.63 Million100.55%
2009 -NZ$14.78 Million-28.56%
2008 -NZ$20.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$59.16 M-150.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$3.63 Million-96.91% Bahamas